BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8106101)

  • 1. Release-regulating dopamine autoreceptors in human cerebral cortex.
    Fedele E; Andrioli GC; Ruelle A; Raiteri M
    Br J Pharmacol; 1993 Sep; 110(1):20-2. PubMed ID: 8106101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
    Wang HY; Zhou LW; Friedman E; Weiss B
    Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM; Barnes NM; Costall B; Naylor RJ
    Neuropharmacology; 1990 Apr; 29(4):327-36. PubMed ID: 1971430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors.
    Wedzony K; Limberger N; Späth L; Wichmann T; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):250-5. PubMed ID: 3264055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native human neocortex release-regulating dopamine D2 type autoreceptors are dopamine D2 subtype.
    Fedele E; Fontana G; Munari C; Cossu M; Raiteri M
    Eur J Neurosci; 1999 Jul; 11(7):2351-8. PubMed ID: 10383624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]GABA on rat prefrontal cortex slices.
    Rétaux S; Besson MJ; Penit-Soria J
    Neuroscience; 1991; 42(1):61-71. PubMed ID: 1677746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.
    Momiyama T; Sasa M; Takaori S
    Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
    Kamijo N; Nagao T; Ono H
    Neuropharmacology; 1993 Aug; 32(8):777-83. PubMed ID: 8105410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.
    Rump LC; Schwertfeger E; Schuster MJ; Schaible U; Frankenschmidt A; Schollmeyer PJ
    Kidney Int; 1993 Jan; 43(1):197-204. PubMed ID: 8094472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between dopamine D1 and D2 receptors in the model of thyrotropin-releasing hormone (TRH)-induced behaviour in rabbits.
    Popoli P; Caporali MG; Scotti de Carolis A
    Eur J Pharmacol; 1991 Aug; 201(1):11-6. PubMed ID: 1686587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
    Evans AM; Green KL
    Br J Pharmacol; 1991 Dec; 104(4):787-92. PubMed ID: 1687366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple biological way to screen dopaminergic agonists.
    de Azeredo FA; Ribeiro MF
    Metab Brain Dis; 1992 Dec; 7(4):211-21. PubMed ID: 1363485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1993 Apr; 234(2-3):155-63. PubMed ID: 8097720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dopamine D1 and D2 receptor agonists on inositol phosphate turnover in rat striatal slices.
    Gupta SK; Mishra RK
    Biochem Int; 1990 Dec; 22(5):887-94. PubMed ID: 1983069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTH-(1-24) enhances the electrically stimulated release of [3H]dopamine from rat septal slices via a dopamine D2 receptor-independent mechanism.
    Florijn WJ; Versteeg DH
    Brain Res; 1989 Aug; 494(2):247-54. PubMed ID: 2550107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization.
    Harsing LG; Sershen H; Lajtha A
    J Neurochem; 1992 Jul; 59(1):48-54. PubMed ID: 1351932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1991; 103(4):503-12. PubMed ID: 1676528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.